EUVIMEDEUVIMED entdecken
Crossref

Characterizing a lethal CAG-ACE2 transgenic mouse model for SARS-CoV-2 infection using Cas9-enhanced nanopore sequencing

Alexander Smirnov, Artem Nurislamov, Galina Koncevaya, Irina Serova, Evelyn Kabirova, Eduard Chuyko, Ekaterina Maltceva, Maxim Savoskin, Daniil Zadorozhny, Victor A Svyatchenko, Elena V Protopopova, Oleg S Taranov und 4 weitere

Transgenic Research · 2024

DOI: 10.1007/s11248-024-00413-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transgenic Research, 2024. Verfasst von Alexander Smirnov und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090. Hauptthemen laut MEDLINE: COVID-19, Angiotensin-Converting Enzyme 2, Mice, Transgenic, Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Russian Federation, Ministry of Education and Science of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS-CoV-2 pandemic has underscored the necessity for functional transgenic animal models for testing. Mouse lines with overexpression of the human receptor ACE2 serve as the common animal model to study COVID-19 infection. Overexpression of ACE2 under a strong ubiquitous promoter facilitates convenient and sensitive testing of COVID-19 pathology. We performed pronuclear microinjections using a 5 kb CAG-ACE2 linear transgene construct and identified three founder lines with 140, 72, and 73 copies, respectively. Two of these lines were further analyzed for ACE2 expression profiles and sensitivity to SARS-CoV-2 infection. Both lines expressed ACE2 in all organs analyzed. Embryonic fibroblast cell lines derived from transgenic embryos demonstrated severe cytopathic effects following infection, even at low doses of SARS-CoV-2 (0,1-1.0 TCID50). Infected mice from the two lines began to show COVID-19 clinical signs three days post-infection and succumbed between days 4 and 7. Histological examination of lung tissues from terminally ill mice revealed severe pathological alterations. To further characterize the integration site in one of the lines, we applied nanopore sequencing combined with Cas9 enrichment to examine the internal transgene concatemer structure. Oxford Nanopore sequencing (ONT) is becoming the gold standard for transgene insert characterization, but it is relatively inefficient without targeted region enrichment. We digested genomic DNA with Cas9 and gRNA against the ACE2 transgene to create ends suitable for ONT adapter ligation. ONT data analysis revealed that most of the transgene copies were arranged in a head-to-tail configuration, with palindromic junctions being rare. We also detected occasional plasmid backbone fragments within the concatemer, likely co-purified during transgene gel extraction, which is a common occurrence in pronuclear microinjections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Angiotensin-Converting Enzyme 2Mice, TransgenicDisease Models, AnimalSARS-CoV-2AnimalsMiceHumansNanopore SequencingCRISPR-Cas SystemsTransgenesLungPandemics

Stichwörter der Autor:innen

COVID-19Mouse modelNanopore sequencingSARS-CoV-2Transgenic micehACE2

Substanzen

Angiotensin-Converting Enzyme 2ACE2 protein, humanAce2 protein, mouse

Autor:innen und Institutionen

  • Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.
  • Novosibirsk State University, Novosibirsk, Russia, 630090.
  • Center for Genetics and Life Science, Sirius University of Science and Technology, Sochi, Russia, 354340.
  • State Research Center for Virology and Biotechnology "Vector", Novosibirsk, Koltsovo, Russia, 630559.
  • Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090. battulin@gmail.com.
  • Novosibirsk State University, Novosibirsk, Russia, 630090. battulin@gmail.com.

Förderung

  • Ministry of Science and Higher Education of the Russian Federation
  • Ministry of Education and Science of the Russian Federation

Zitieren

APA

Smirnov, A., Nurislamov, A., Koncevaya, G., Serova, I., Kabirova, E., Chuyko, E., Maltceva, E., Savoskin, M., Zadorozhny, D., Svyatchenko, V. A., Protopopova, E. V., Taranov, O. S., Legostaev, S. S., Loktev, V. B., Serov, O., & Battulin, N. (2024). Characterizing a lethal CAG-ACE2 transgenic mouse model for SARS-CoV-2 infection using Cas9-enhanced nanopore sequencing. Transgenic Research. https://doi.org/10.1007/s11248-024-00413-w

Vancouver

Smirnov A, Nurislamov A, Koncevaya G, Serova I, Kabirova E, Chuyko E, et al. Characterizing a lethal CAG-ACE2 transgenic mouse model for SARS-CoV-2 infection using Cas9-enhanced nanopore sequencing. Transgenic Research. 2024. doi:10.1007/s11248-024-00413-w

BibTeX
@article{Smirnov2024,
  author = {Smirnov, Alexander and Nurislamov, Artem and Koncevaya, Galina and Serova, Irina and Kabirova, Evelyn and Chuyko, Eduard and Maltceva, Ekaterina and Savoskin, Maxim and Zadorozhny, Daniil and Svyatchenko, Victor A and Protopopova, Elena V and Taranov, Oleg S and Legostaev, Stanislav S and Loktev, Valery B and Serov, Oleg and Battulin, Nariman},
  title = {Characterizing a lethal CAG-ACE2 transgenic mouse model for SARS-CoV-2 infection using Cas9-enhanced nanopore sequencing},
  journal = {Transgenic Research},
  year = {2024},
  doi = {10.1007/s11248-024-00413-w}
}
Kostenlos starten →